Mike Lustgarten presents a detailed self-experiment combining NAD+ precursors (nicotinic acid, nicotinamide, and NMN) with homocysteine-lowering supplements (riboflavin, betaine/TMG, and zinc) over a 41-day period, culminating in blood testing. He measures outcomes using Dr. Morgan Lavine's Pheno Age calculator (a blood-based biological age estimator using nine clinical chemistry biomarkers) and direct NAD+ quantification via Zymo Research. His NAD+ increased from 21 µM (previous test with nicotinamide alone) to 48 µM with NMN supplementation, which he attributes partly to the monucleotide addition to nicotinamide. His homocysteine measured 9.3 µM, below the clinical high-threshold of 15 µM, though he targets 5 µM based on published literature correlating homocysteine with aging and mortality risk.
Lustgarten demonstrates notable intellectual honesty by acknowledging a critical limitation: despite achieving favorable individual biomarker results, his biological age showed a 15-year advantage—his worst result across seven tests. He explicitly questions whether his multi-supplement protocol improved biomarker data or potentially worsened it, explicitly stating "one could make the argument that all of these supplements didn't do anything." This candor is rare in longevity content. He also discloses methodological details (custom stock solutions, dose averaging over 41 days, headaches prompting dose reductions) and notes that NAD+ levels change rapidly with supplementation changes, potentially confounding interpretation.
However, significant evidentiary gaps exist. The video cites no peer-reviewed studies establishing that S-adenosylmethionine (SAM) or the specific supplement stack reduces homocysteine or improves aging outcomes in humans. While homocysteine's neurotoxicity and association with endothelial senescence are mentioned, no citations are provided. His 'optimal' homocysteine target (5 µM) and NAD+ interpretation (citing metabolomic correlations) lack published references in this segment. The Pheno Age calculator itself is peer-reviewed, but whether a 15-year biological age advantage (even as his worst result) translates to longevity or health gains remains unestablished. His new Patreon tier claiming optimized biomarker targets across 35 markers references 52 published papers, but viewers cannot assess their quality or applicability without access.
The experiment is fundamentally a single n=1 case study without control conditions, blinding, or randomization. Lustgarten is not a credentialed aging researcher (his background is in finance/data analysis based on public information), though he demonstrates strong scientific literacy and careful self-measurement. The video conflates correlation (metabolomic associations with NAD+) with causation and lacks clarity on whether supplement timing, interactions, or external confounders (diet, stress, sleep during the 41-day period) influenced results.
Viewers should understand this as detailed biohacking documentation rather than evidence that this supplement protocol extends lifespan or improves aging. The candid acknowledgment that his 'worst' biological age result accompanied his most intensive supplementation is the video's most valuable contribution—it challenges the assumption that more interventions equal better outcomes.
0 Comments
Log in to join the discussion.